The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was forced out.

The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next ...

Dr. Vinay Prasad, a vocal critic of the agency's moves to greenlight COVID-19 vaccine boosters. Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation ...

Vinay Prasad will serve as director of the FDA's Center for Biologics Evaluation and Research, which oversees vaccine and ...

Vinay Prasad, a critic of the Food and Drug Administration ... at San Francisco professor and epidemiologist, will replace Peter Marks, whom the Trump administration forced out in late March.